VIVOSTART
LIVE

Serial Number

97490617

Owner

BioIVT Holdings, LLC

Attorney

CHUN T. WRIGHT

Filing Date

Jul 6, 2022

Add to watchlist:

No watchlists yet
View on USPTO

VIVOSTART Trademark

Serial Number: 97490617

VIVOSTART is a trademark filed by BioIVT Holdings, LLC on July 6, 2022. The trademark is classified under Class 1 (Chemicals), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

BioIVT Holdings, LLC

Suite 115
Westbury, NY 11590

Entity Type: 16

Trademark Details

Filing Date

July 6, 2022

Registration Date

Not Registered

Published for Opposition

October 10, 2023

Goods & Services

Distribution services, namely, delivery of cells, sub-cellular fractions, antibodies, reagents, culture media, and biological tissue, namely, immune cells, bone marrow, and pooled serum from either plasma or whole blood

Manufacturing and processing of cells in the field of cell therapies for medical and scientific research; Bone marrow aspiration for medical and scientific research; Research and development services in the field of cell therapies; Custom production and manufacture of advanced therapeutics such as cell and gene therapies for others for medical and scientific research; Leukapheresis collections from normal, healthy human donors for use as a source material for manufacturing and processing of cells for laboratory, medical and scientific research; Cell therapy services, namely, manufacturing and processing of Human AB serum and leukapheresis material for human biotherapies and in vivo therapies for laboratory, medical and scientific research; Medical services for cell sampling and isolation, namely, leukapheresis medical treatment services for laboratory, medical and scientific research

Cells, sub-cellular fractions, antibodies, reagents and culture media for scientific, laboratory, and research use; Immune cells isolated from leukapheresis collections by immunomagnetic or density gradient separation from normal, healthy human donors for scientific, laboratory, and research use; Human AB serum derived from either plasma or whole blood from normal, healthy male human donors with AB blood type for scientific, laboratory, research, and further manufacturing use

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 5, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 5, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 5, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2026 EXRA
SOU EXTENSION 5 GRANTED
Apr 27, 2026 EX5G
SOU TEAS EXTENSION RECEIVED
Mar 26, 2026 EEXT
SOU EXTENSION 5 FILED
Mar 25, 2026 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Dec 2, 2025 EX4G
SOU EXTENSION 4 FILED
Dec 2, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 2, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 19, 2025 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 23, 2025 EXRA
SOU EXTENSION 3 GRANTED
May 22, 2025 EX3G
SOU EXTENSION 3 FILED
May 22, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
May 22, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 12, 2024 EXRA
SOU EXTENSION 2 GRANTED
Dec 12, 2024 EX2G
SOU EXTENSION 2 FILED
Nov 26, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 26, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2024 EXRA
SOU EXTENSION 1 GRANTED
Aug 14, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 12, 2024 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jun 6, 2024 TPEX
NOTICE OF REVIVAL - E-MAILED
Jun 6, 2024 NREV
PETITION TO REVIVE-GRANTED
Jun 6, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Jun 6, 2024 PROA
SOU EXTENSION 1 FILED
Jun 5, 2024 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 5, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 10, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 10, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 21, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2022 NWOS
NEW APPLICATION ENTERED
Jul 9, 2022 NWAP